Trial Design

INSIGHTS ON CLINICAL TRIAL DESIGN

Turning Rapid Study Start-Up Into Enrollment Momentum
A large Phase III ATTR-CM outcomes trial spanning 37 countries reached 50% enrollment eight months early, with monthly accrual rates running 3–5x above plan through coordinated cross-functional execution.
ICH E6(R3) Annex 2: Navigating GCP Requirements For Decentralized Trials
Implementing decentralized components or real-world data requires proactive alignment with updated GCP standards for data access, remote consent, and multi-stream investigator oversight.
Obesity Clinical Research: Patient Recruitment Challenges
Obesity trials face enrollment hurdles. Learn how data-driven insights, patient-first strategies, and decentralized models can break barriers, ease burden, and accelerate timelines.
Breaking Through Barriers With Integrated Trial Optimization
In today’s complex clinical trial environment, optimizing trial design requires a multidimensional strategy that balances scientific rigor with real-world constraints.

Mergers And Acquisitions: How Institutional Knowledge Protecting Value
5/27/2026

M&A transitions can either preserve momentum or create costly setbacks. Learn how protecting institutional knowledge helps sponsors reduce risk, maintain continuity, and accelerate development.
Ocular Endpoint Protection In A Capital-Constrained Market
9/3/2025

Ocular Endpoint Protection reframes data capture as a non-negotiable driver of efficiency, and sponsors who embed point-of-need (PON) into their protocols protect both their investment and results.
Effective Study Design And Execution Of Renal And Hepatic Impairment Trials
5/1/2026

Master the complexities of renal and hepatic trials by leveraging site expertise and PK modeling to navigate recruitment challenges and ensure precise dosing for impaired populations.
Sol-Gel Builds Awareness Of Rare Skin Condition, Generates Leads
4/1/2026

Explore a 60-day HCP Awareness email campaign that surpassed industry benchmarks and generated a substantial number of leads.
Protocol Builder And Informed Consent Builder Version 2.0
9/16/2026

Built by research compliance experts, this platform streamlines the protocol-writing process through customizable templates, workflow tools, and collaboration support for research teams.

The North American Advantage

With more than 80% of Avance Clinical’s biotech clients located in North America, the region has played a significant role in the almost three decades of the company’s growth.
De-Risk Randomization With The Endpoint Biostatistical Approach

With over 15 years of RTSM experience, high-touch quality management, and forward-thinking technology, our solutions enhance trial speed, accuracy, and operational efficiency.
Premier Service Provider For Driving Simulator Clinical Trials

With over 13,000 drives completed and 10 driving simulators on-site, Altasciences is the ideal full-service provider for your driving simulator clinical trials.
Home Trial Support: The Engine Powering DCT

By conducting trial visits outside of the site, physicians can expand their reach, making drug development more accessible. Read about how MRN's Home Trial Support "HTS" is the engine powering DCTs.
Bold Thinking Overcomes Oncology Clinical Development Challenges

Veristat ensures that your clinical trial or program design supports your regulatory strategy, whether you plan to run a single pivotal trial or multiple trials.